✦ LIBER ✦

Reduction of suppressor cell activity by OS-432 through the inhibition of suppressor inducer T cells

✍ Scribed by T. Toge; K. Kuroi; A. Sawamura; H. Kuninobu; T. Hattori

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 78 KB
Volume: 10
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(88)90369-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interference of the induction of suppres

Interference of the induction of suppressor cells by a streptococcal preparation, OK-432 through the blocking of suppressor inducer T-cells

✍ Tetsuya Toge; Katsumasa Kuroi; Nobutoshi Baba; Yasuhide Kegoya; Takahiko Takayam 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Reduction of suppressor cell activities

Reduction of suppressor cell activities by OK-432 immunotherapy in cancer patients

✍ T. Toge; Y. Seto; K. Shimura; T. Hattori 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Effect of unsymmetrical dimethylhydrazin

Effect of unsymmetrical dimethylhydrazine on concanavalin and prostaglandin-induced T-cell suppressor factor induced suppressor cell activity

✍ Devraj J. Pillay; Melinda J. Tarr; Richard G. Olsen 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Cimetidine blocks the development of tum

Cimetidine blocks the development of tumor-induced suppressor T cell activity

✍ James A. Bennett; Peter Zloty; Martin F. McKneally 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Reduction of suppressor cell activities

Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432

✍ Tetsuya Toge; Hirofumi Yamada; Kiyoshi Aratani; Masahiro Yamaguchi; Tsuyoshi Fuj 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Intrapleural administration of OK432 in

Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells

✍ Atsushi Uchida; Michael Micksche 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 547 KB

## Abstract Twelve patients with carcinomatous pleural effusions were treated with single intrapleural (i.pl.) administration of OK432 on day 0 and the effects of i.pl. OK432 on natural killer (NK) cell activity were followed on day 7. Two patients showed no clinical evidence of therapeutic benefit